Commentary: A nuclear winter is coming for biopharma

The biotech and pharmaceutical sectors are foundational to the Massachusetts economy. Despite the centrality of the life sciences sector to the state’s economy, the Massachusetts political class has always been slightly ambivalent about supporting this largely for-profit sector of healthcare. Politicians here are much more likely to use talking points in their town hall meetings that criticize “greedy drug companies” rather than supporting a sector that provides enormous economic benefit.


Previous Table of Experts: Industrial developers
Next Biz: Raleigh's Blue Ridge Corridor looks to make leap; Big Chapel Hill project advances